Learn about the global Implantable Drug Delivery Devices market through The Business Research Company, which provides information on implantable drug delivery devices market size, implantable drug delivery devices market drivers and restraints, implantable drug delivery devices market players, the COVID-19 impact on the implantable drug delivery devices market, and more.

The global implantable drug delivery devices market size is expected to grow from $17.20 billion in 2021 to $18.35 billion in 2022 at a compound annual growth rate (CAGR) of 6.7%. The global implantable drug delivery market is then expected to grow to $24.08 billion in 2026 at a CAGR of 7.0%.

The rise in the incidence of target diseases such as diabetic retinopathy, cancer, cardiovascular diseases, and other chronic diseases is expected to drive the implantable drug delivery devices market.

Request A Sample For The Global Implantable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3303&type=smp

The implantable drug delivery devices market consists of sales of implantable drug delivery devices and related services by companies that manufacture them. Implantable drug delivery devices are drug delivery systems implanted by surgery to allow site-specific drug administration at the tissue or organ where the drug is most needed.

Global implantable drug delivery devices market segments include:

By Product: Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-Absorbable Stents, Intraocular Stents, Infusion Pumps, Others

By Technology: Diffusion, Osmotic, Magnetic, Others

By Application: Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the implantable drug delivery devices market in 2021.

Companies and researchers are focusing on developing 3D implantable drug delivery devices. 3D printed titanium transcutaneous ports are implanted behind the patient’s ear, allowing healthcare professionals to access the catheters.

TBRC’s implantable drug delivery devices market report covers:

Major Market Players: Allergan Inc, Bayer HealthCare, Medtronic Inc, Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc, Merck, Genetech Inc, and Psivida.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Implantable Drug Delivery Devices Global Market Report 2022– Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides implantable drug delivery devices market overviews, analyzes and forecasts market size, share, implantable drug delivery devices market players, implantable drug delivery devices market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s implantable drug delivery devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Injectable Drug Delivery Devices Global Market Report 2022

Drug Delivery Devices Global Market Report 2022

Microneedle Drug Delivery Systems Global Market Report 2022

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model